Background: Long-acting bronchodilator inhalers are widely used with or without inhaled corticosteroids (ICs) by patients with lung diseases. In Israel alone, there are 21 inhalers containing long-acting β2 agonists (LABAs) and/or long-acting muscarinic antagonists (LAMAs). Some patients are treated incorrectly with several inhalers of the same pharmacologic group.

中文翻译：

---

长效支气管扩张剂吸入器的重复处方率

背景：肺部疾病患者广泛使用长效支气管扩张剂吸入器，有或没有吸入皮质类固醇 (IC)。仅在以色列，就有 21 种含有长效 β2 激动剂 (LABA) 和/或长效毒蕈碱拮抗剂 (LAMA) 的吸入器。一些患者使用同一药理学组的几种吸入器进行了不正确的治疗。